Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil in Children and Adolescents With ADHD (C1538/3044/AD/US)
NCT00228540Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of modafinil in attention deficit hyperactivity disorder (ADHD), sponsored by Cephalon, Inc. Primary endpoint: Attention-Deficit/Hyperactivity Disorder Rating Scale - IV at 8 weeks. Started Sep 2005; status: completed.
02
Drugs
modafinil
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00228540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228540.